Recombinant Human TACI (TNFRSF13B)
TACI, a member of the TNF Receptor superfamily, is expressed in the small intestine, spleen, thymus, peripheral blood leukocytes, activated T cells, and resting B cells. TACI binds to both APRIL and BAFF and can stimulate the activation of transcription factors; NF-kappaB, AP-1, and mediates calcineurin dependent activation of NF-AT (nuclear-factor of activated T cells). TACI also plays a key role in the stimulation of B and T cell function. Soluble TACI inhibits APRIL-stimulated proliferation of primary B-cells by blocking the binding of APRIL to the membrane anchored TACI receptor. Recombinant human TACI is a soluble 159 amino acid polypeptide (17.8 kDa) comprising the TNFR homologous cysteine rich extracellular domain of the TACI protein. MK 2208 (dihydrochloride)
Source: |
E. Coli
|
  | |
Purity:
|
Above 98% as determined by SDS-PAGE Analysis.
|
  | |
Cross Reactivity: |
NULL
|
  | |
Biological Activity
|
Determined by its ability to block human BAFF induced T2B cell survival using a concentration range of 1.0-3.0 µg/ml.
|
  | |
AA Sequence
|
SGLGRSRRG GRSRVDQEE RFPQGLWTG VAMRSCPEE QYWDPLLGT CMSCKTICN HQSQRTCAA FCRSLSCRK EQGKFYDHL LRDCISCAS ICGQHPKQC AYFCENKLR SPVNLPPEL RRQRSGEVE NNSDNSGRY QGLEHRGSE ASPALPGLK LSADQV
|
Research Interest: | , , Inflammation |
Cell Type: | , |
Protein Cross Reactivity: | NULL |